Dr. Bonde (left) talks to Whittel about his recovery.
(left) talks to Whittel
about his recovery.
However, Dr. Bonde, who joined Yale Medical Group in September as surgical director of Mechanical Circulatory Support, also specializes in LVAD surgery as a "destination therapy," or permanent solution.
Before coming to Yale, Dr. Bonde practiced at Johns Hopkins Hospital and UPMC, where he accrued an extensive record of outstanding clinical outcomes in LVAD implantation and such cardiac surgeries as bypass surgery, valve repairs and aortic surgeries.
is a patient who, from a medical point of view, had a very sick heart," says Dr. Bonde
discussed the case extensively with fellow heart failure cardiologists.
The device, which Dr. Bonde
says will function for several years, essentially takes over the work Whittel
's ailing heart can no longer do.
still has months of physical and cardiac therapy ahead of him, as well as follow-up visits to monitor his
stability and endurance.
But soon after the procedure he
physical therapy with such gusto that he
earned himself an early release from the hospital.
happy to talk about the mile-long walk he
recently took on an even grade and his
shorter strolls in his
family's hilly neighborhood.
"I'm learning that I have to change some of my daily activities because of the equipment," he
Pramod Bonde, MD, is hoping to provide patients with better LVADs in the future.
has developed a wireless micro-LVAD that switches on only when the patient needs it, much like a pacemaker does.
For patients whose hearts have the potential to recover, this would allow the actual heart muscle to do the work when it is able, strengthening it.
But the LVAD would serve as a failsafe, switching on should the heart fail to pump.
This lower impact device would be appropriate to implant in patients in the early stages of heart failure-long before they get to the dangerous and debilitating stage that the Rev. Joseph Whittel
has been watching LVADs and their batteries shrink and improve over the years.
In 2008, he
teamed up with Joshua Smith, a professor of computer science and electrical engineering at the University of Washington.
Together they developed a prototype of the wireless device that has worked in the lab, but he
will not be able to provide it for patients until it is commercially available.
says the wireless pump could be implanted with minimally invasive "keyhole-type" surgery.
is looking forward to the day when the Bonde-Smith model would eliminate those problems.